Literature DB >> 23287451

Early cardiac retention of administered stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy.

Birgit Assmus, Andreas M Zeiher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23287451     DOI： 10.1161/CIRCRESAHA.112.300341

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  6 in total

Review 1.  Cardiac regeneration: current therapies-future concepts.

Authors:  Stefanie A Doppler; Marcus-André Deutsch; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 2.  Stem cells and diabetic cardiomyopathy: from pathology to therapy.

Authors:  Mingfei Liu; Han Chen; Jun Jiang; Zhaocai Zhang; Chen Wang; Na Zhang; Liang Dong; Xinyang Hu; Wei Zhu; Hong Yu; Jian'an Wang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 3.  Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes.

Authors:  Jean-Sébastien Hulot; Francesca Stillitano; Joe Elie Salem; Jason C Kovacic; Valentin Fuster; Roger J Hajjar
Journal:  Stem Cell Res Ther       Date:  2014-01-09       Impact factor: 6.832

Review 4.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

5.  Cell-Based Therapies for Heart Failure.

Authors:  Antonio Carlos Campos de Carvalho; Tais H Kasai-Brunswick; Adriana Bastos Carvalho
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

6.  Vibrational Spectroscopy-Based Chemometrics Analysis of Clinacanthus nutans Extracts after Postharvest Processing and Extract Effects on Cardiac C-Kit Cells.

Authors:  Vuanghao Lim; Hui Wen Chong; Nozlena Abdul Samad; Siti Aisyah Abd Ghafar; Ida Shazrina Ismail; Rafeezul Mohamed; Yoke Keong Yong; Chee Yuen Gan; Jun Jie Tan
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-23       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.